Paul Barrett and Robert Langreth (Bloomberg Businessweek)
How to Know When a New Target is Really a New Target
Derek Lowe (In the Pipeline)
Nutrition science isn’t broken, it’s just wicked hard
Jenna Gallegos (Washington Post)
A Reality Check for IBM’s AI Ambitions
David Freedman (MIT Technology Review)
A head above the rest? Drugmakers face off in migraine market
Ned Pagliarulo (BioPharm Dive)
Drugmakers’ Money-Back Guarantees: an Answer to Rising Prices or a ‘Carnival Game’
Charles Ornstein (ProPublica) and Katie Thomas (New York Times)
The art of the deal? Why a money-back guarantee for drugs is a bad idea
Ed Silverman (STAT News)
The Sidewalk Pill Peddlers Of Port-Au-Prince
Sasha Ingber (NPR)